Market Research Logo

Pharmaceutical Glass Packaging Market Size, Share & Trends Analysis Report By Product (Vials, Ampoules, Cartridges & Syringes), By Drug Type (Generic, Branded, Biologic), And Segment Forecasts, 2018 - 2025

Pharmaceutical Glass Packaging Market Size, Share & Trends Analysis Report By Product (Vials, Ampoules, Cartridges & Syringes), By Drug Type (Generic, Branded, Biologic), And Segment Forecasts, 2018 - 2025

The global pharmaceutical glass packaging market size is expected to reach USD 22.05 billion by 2025, according to a new report by Grand View Research, Inc., registering a CAGR of 6.3% during the forecast period. Spiraling sale of generic drugs in developed as well as developing economies is projected to drive the demand for pharmaceutical glass packaging. Glass has a well-defined supply chain in the pharmaceutical industry and is traditionally used for parenteral drug packaging. Extensive R&D is being conducted by product manufacturers in order to minimize negative aspects of glass, such as high susceptibility to breaking and delamination, as well as to improve the quality & efficacy of the product.

The pharmerging market is anticipated to witness phenomenal growth owing to favorable government policies and increased healthcare awareness. Governments of developing nations are expanding their public or private healthcare coverage and simultaneously making efforts to minimize out-of-pocket medical expenses for the consumers. Increasing government efforts to reduce healthcare cost and promotion of low-cost generic drugs are estimated to fuel the utilization of glass packaging over the coming years.

Emergence of novel drugs such as cancer drugs and bio-therapeutics is likely to help the market gain traction over the coming years. In an effort to safeguard patient health, guidelines for packaging of biological drugs have been made highly stringent, which necessitates constant development in the field of pharmaceutical packaging. Aforementioned factors promote manufacturers to adopt advanced techniques, thereby driving the market.

In primary pharmaceutical packaging, glass has an advantage over plastic as plastic production requires raw materials such as polyethylene, polypropylene, and polystyrene, which are largely dependent on fluctuating petroleum industry. Manufacturers use soda lime, quartz, and other additives for manufacturing glass. These raw materials are easily available in the market by numerous suppliers. Recent developments in the pharmaceutical glass packaging include launch of Gx Baked-On RTF and an Omniflex plunger, a prefilled syringe, by Gerresheimer AG in September 2017. This technology has the ability to minimize particle loads and meet strict requirements for therapeutic protein products for better deliver of drug.

Further Key Findings from the Report Suggest:

  • The vials segment is projected to ascend at a CAGR of 6.9% in terms of revenue over the forecast period
  • The bottles segment dominated the global pharmaceutical glass packaging market in 2016 in terms of revenue and is anticipated to witness a CAGR of 4.7% from 2017 to 2025 owing to high penetration of plastics in the manufacturing of bottles
  • The generic drug segment accounted for 69.8% of the market in 2016 due to rapidly increasing manufacturing volumes of generic drugs in emerging economies
  • Europe is expected to witness considerable growth during the forecast period owing to constant development in the medical field aimed at improving health and quality of life
  • Some of the key companies present in the market are Corning Incorporated; Gerresheimer AG; Nipro Pharmapackaging; SCHOTT AG; Şişecam Group; Arab Pharmaceutical Glass Co.; Beatson Clark; Stevanato Group; and Owens-Illinois, Inc.


Chapter 1 Methodology And Scope
1.1 Research methodology
1.2 Research scope & assumptions
1.3 List of data sources
Chapter 2 Executive Summary
2.1 Market snapshot
Chapter 3 Market Variables, Trends & Scope
3.1 Market segmentation & scope
3.1.1 Penetration & growth prospect mapping
3.2 Pharmaceutical glass packaging - Value chain analysis
3.3 Raw material trend
3.3.1 Type I - Borosilicate glass (e.g. Pyrex, Borosil)
3.3.2 Boric oxide
3.3.3 Type II Treated soda-lime glass
3.3.4 Type III Regular soda-lime glass
3.4 Regulatory framework
3.4.1 International Organization for Standardization
3.4.2 Occupational Health and Safety Management Certification
3.4.3 US Food and Drug Administration
3.5 Market dynamics
3.5.1 Market driver analysis
3.5.1.1 Growth of pharmaceutical industry in emerging economies
3.5.1.2 Commodity value of glass increased with recyclability:
3.5.2 Market restraint analysis
3.5.2.1 Increased relevance of alternate sources
3.5.2.2 Challenges associated with glass surface
3.6 Pharmaceutical glass packaging market - PESTEL analysis
3.7 Pharmaceutical glass packaging market - Porter’s analysis
Chapter 4 Pharmaceutical Glass Packaging Market: Product Estimates & Trend Analysis
4.1 Pharmaceutical glass packaging market: Product movement analysis
4.2 Vials
4.2.1 Pharmaceutical glass vials market estimates & forecasts, 2014 - 2025 (USD Million)
4.2.2 Pharmaceutical glass vials packaging market estimates & forecasts, by product, 2014 - 2025 (USD Million)
4.3 Bottles
4.3.1 Pharmaceutical glass bottle market estimates & forecasts, 2014 - 2025 (USD Million)
4.3.2 Pharmaceutical glass bottle market estimates & forecasts, by product, 2014 - 2025 (USD Million)
4.4 Cartridges & Syringes
4.4.1 Pharmaceutical glass cartridges & syringes market estimates & forecasts, 2014 - 2025 (USD Million)
4.5 Ampoules
4.5.1 Pharmaceutical glass ampoules market estimates & forecasts, 2014 - 2025 (USD Million)
Chapter 5 Pharmaceutical Glass Packaging Market: Drug Type Estimates & Trend Analysis
5.1 Pharmaceutical glass packaging market: Drug type movement analysis
5.1.1 Generic drugs
5.1.1.1 Pharmaceutical glass packaging market estimates & forecasts in generic drugs, 2014 - 2025 (USD Million)
5.1.2 Branded drugs
5.1.2.1 Pharmaceutical glass packaging market estimates & forecasts in branded drugs, 2014 - 2025 (USD Million)
5.1.3 Biologic drugs
5.1.3.1 Pharmaceutical glass packaging market demand in biologic drugs, 2014 - 2025 (USD Million)
Chapter 6 Pharmaceutical Glass Packaging Market: Regional Estimates & Trend Analysis
6.1 Regional Movement Analysis & Market Share, 2016 & 2025
6.2 North America Movement Analysis & Market Share, 2016 & 2025
6.2.1 North America market estimates and forecast, by product (USD Million)
6.2.2 North America market estimates and forecast, by drug type (USD Million)
6.2.3 U.S. pharmaceutical glass packaging market share, 2016 & 2025
6.2.3.1 U.S. market estimates and forecast, by product (USD Million)
6.2.3.2 U.S. market estimates and forecast, by drug type (USD Million)
6.3 Europe Movement Analysis & Market Share, 2016 & 2025
6.3.1 Europe market estimates and forecast, by product (USD Million)
6.3.2 Europe market estimates and forecast, by drug type (USD Million)
6.3.3 Germany pharmaceutical glass packaging market share, 2016 & 2025
6.3.3.1 Germany market estimates and forecast, by product (USD Million)
6.3.3.2 Germany market estimates and forecast, by drug type (USD Million)
6.3.4 U.K. pharmaceutical glass packaging market share, 2016 & 2025
6.3.4.1 U.K. market estimates and forecast, by product (USD Million)
6.3.4.2 U.K. market estimates and forecast, by drug type (USD Million)
6.3.5 France pharmaceutical glass packaging market share, 2016 & 2025
6.3.5.1 France market estimates and forecast, by product (USD Million)
6.3.5.2 France market estimates and forecast, by drug type (USD Million)
6.3.6 Spain pharmaceutical glass packaging market share, 2016 & 2025
6.3.6.1 Spain market estimates and forecast, by product (USD Million)
6.3.6.2 Spain market estimates and forecast, by drug type (USD Million)
6.3.7 Italy pharmaceutical glass packaging market share, 2016 & 2025
6.3.7.1 Italy market estimates and forecast, by product (USD Million)
6.3.7.2 Italy market estimates and forecast, by drug type (USD Million)
6.4 Asia Pacific Movement Analysis & Market Share, 2016 & 2025
6.4.1 Asia Pacific market estimates and forecast, by product (USD Million)
6.4.2 Asia Pacific market estimates and forecast, by drug type (USD Million)
6.4.3 China pharmaceutical glass packaging market share, 2016 & 2025
6.4.3.1 China market estimates and forecast, by product (USD Million)
6.4.3.2 China market estimates and forecast, by drug type (USD Million)
6.4.4 Japan pharmaceutical glass packaging market share, 2016 & 2025
6.4.4.1 Japan market estimates and forecast, by product (USD Million)
6.4.4.2 Japan market estimates and forecast, by drug type (USD Million)
6.4.5 India pharmaceutical glass packaging market share, 2016 & 2025
6.4.5.1 India market estimates and forecast, by product (USD Million)
6.4.5.2 India market estimates and forecast, by drug type (USD Million)
6.4.6 South Korea pharmaceutical glass packaging market share, 2016 & 2025
6.4.6.1 South Korea market estimates and forecast, by product (USD Million)
6.4.6.2 South Korea market estimates and forecast, by drug type (USD Million)
6.5 CSA Movement Analysis & Market Share, 2016 & 2025
6.5.1 CSA market estimates and forecast, by product (USD Million)
6.5.2 CSA market estimates and forecast, by drug type (USD Million)
6.5.3 Brazil pharmaceutical glass packaging market share, 2016 & 2025
6.5.3.1 Brazil market estimates and forecast, by product (USD Million)
6.5.3.2 Brazil market estimates and forecast, by drug type (USD Million)
6.6 MEA Movement Analysis & Market Share, 2016 & 2025
6.6.1 MEA market estimates and forecast, by product (USD Million)
6.6.2 MEA market estimates and forecast, by drug type (USD Million)
Chapter 7 Competitive Landscape
7.1 Competitive environment
7.2 Price Trend Analysis
7.3 Vendor landscape
7.4 Strategy framework
7.5 Company Market Positioning
7.6 List Of Key Pharma Companies, By Country
7.6.1 U.S.
7.6.1.1 Johnson & Johnson Services, Inc.
7.6.1.1.1 Company overview
7.6.1.1.2 Regional Sales
7.6.1.1.3 Drug Portfolio
7.6.1.2 Pfizer Inc.
7.6.1.2.1 Company overview
7.6.1.2.2 Regional Sales
7.6.1.2.3 Drug Portfolio
7.6.1.3 Abbott
7.6.1.3.1 Company overview
7.6.1.3.2 Regional Sales
7.6.1.3.3 Drug Portfolio
7.6.1.4 Bristol-Myers Squibb Company
7.6.1.4.1 Company overview
7.6.1.4.2 Regional Sales
7.6.1.4.3 Drug Portfolio
7.6.1.5 Amgen Inc.
7.6.1.5.1 Company overview
7.6.1.5.2 Regional Sales
7.6.1.5.3 Drug Portfolio
7.6.1.6 Biogen
7.6.1.6.1 Company overview
7.6.1.6.2 Regional Sales
7.6.1.6.3 Drug Portfolio
7.6.1.7 Celgene Corporation
7.6.1.7.1 Company overview
7.6.1.7.2 Regional Sales
7.6.1.7.3 Drug Portfolio
7.6.1.8 Merck & Co., Inc.
7.6.1.8.1 Company overview
7.6.1.8.2 Regional Sales
7.6.1.8.3 Drug Portfolio
7.6.1.9 Eli Lilly and Company
7.6.1.9.1 Company overview
7.6.1.9.2 Regional Sales
7.6.1.9.3 Drug Portfolio
7.6.1.10 Gilead Sciences, Inc.
7.6.1.10.1 Company overview
7.6.1.10.2 Regional Sales
7.6.1.10.3 Drug Portfolio
7.6.2 Germany
7.6.2.1 Bayer AG
7.6.2.1.1 Company overview
7.6.2.1.2 Regional Sales
7.6.2.1.3 Drug Portfolio
7.6.2.2 PHOENIX Pharma SE
7.6.2.2.1 Company overview
7.6.2.2.2 Regional Sales
7.6.2.3 LEO Pharma A/S
7.6.2.3.1 Company overview
7.6.2.3.2 Regional Sales
7.6.2.3.3 Drug Portfolio
7.6.2.4 Boehringer Ingelheim International GmbH.
7.6.2.4.1 Company overview
7.6.2.4.2 Regional Sales
7.6.2.4.3 Drug Portfolio
7.6.2.5 B. Braun Melsungen AG
7.6.2.5.1 Company overview
7.6.2.5.2 Regional Sales
7.6.2.5.3 Drug Portfolio
7.6.2.6 Grünenthal Group
7.6.2.6.1 Company overview
7.6.2.6.2 Regional Sales
7.6.2.6.3 Drug Portfolio
7.6.2.7 AbbVie Inc.
7.6.2.7.1 Company overview
7.6.2.7.2 Regional Sales
7.6.2.7.3 Drug Portfolio
7.6.2.8 Baxter
7.6.2.8.1 Company overview
7.6.2.8.2 Regional Sales
7.6.2.8.3 Drug Portfolio
7.6.2.9 H. Lundbeck A/S
7.6.2.9.1 Company overview
7.6.2.9.2 Drug Portfolio
7.6.2.10 Medigene Ag
7.6.2.10.1 Company overview
7.6.2.10.2 Regional Sales
7.6.2.10.3 Drug Portfolio
7.6.3 France
7.6.3.1 Servier Laboratories
7.6.3.1.1 Company overview
7.6.3.1.2 Drug Portfolio
7.6.3.2 Sanofi S.A.
7.6.3.2.1 Company overview
7.6.3.2.2 Regional Sales
7.6.3.2.3 Drug Portfolio
7.6.3.3 Allergan plc
7.6.3.3.1 Company overview
7.6.3.3.2 Drug Portfolio
7.6.3.4 Novo Nordisk A/S
7.6.3.4.1 Company overview
7.6.3.4.2 Regional Sales
7.6.3.4.3 Drug Portfolio
7.6.3.5 Mylan N.V
7.6.3.5.1 Company overview
7.6.3.5.2 Regional Sales
7.6.3.5.3 Drug Portfolio
7.6.3.6 BioMarin Pharmaceutical Inc.
7.6.3.6.1 Company overview
7.6.3.6.2 Regional Sales
7.6.3.6.3 Drug Portfolio
7.6.3.7 ALK-Abelló A/S
7.6.3.7.1 Company overview
7.6.3.7.2 Regional Sales
7.6.3.7.3 Drug Portfolio
7.6.3.8 Bristol Laboratories Ltd
7.6.3.8.1 Company overview
7.6.3.8.2 Drug Portfolio
7.6.3.9 Regeneron Pharmaceuticals, Inc.
7.6.3.9.1 Company overview
7.6.3.9.2 Regional Sales
7.6.3.9.3 Drug Portfolio
7.6.3.10 Sinclair Pharma plc
7.6.3.10.1 Company overview
7.6.3.10.2 Regional Sales
7.6.3.10.3 Drug Portfolio
7.6.4 U.K.
7.6.4.1 GlaxoSmithKline plc.
7.6.4.1.1 Company overview
7.6.4.1.2 Regional Sales
7.6.4.1.3 Drug Portfolio
7.6.4.2 AstraZeneca
7.6.4.2.1 Company overview
7.6.4.2.2 Regional Sales
7.6.4.2.3 Drug Portfolio
7.6.4.3 Reckitt Benckiser Group plc.
7.6.4.3.1 Company overview
7.6.4.3.2 Regional Sales
7.6.4.3.3 Drug Portfolio
7.6.4.4 Novartis AG
7.6.4.4.1 Company overview
7.6.4.4.2 Regional Sales
7.6.4.4.3 Drug Portfolio
7.6.4.5 F. Hoffmann-La Roche Ltd
7.6.4.5.1 Company overview
7.6.4.5.2 Drug Portfolio
7.6.4.6 Norgine BV
7.6.4.6.1 Company overview
7.6.4.6.2 Regional Sales
7.6.4.6.3 Drug Portfolio
7.6.4.7 Vifor Pharma Group
7.6.4.7.1 Company overview
7.6.4.7.2 Regional Sales
7.6.4.7.3 Drug Portfolio
7.6.4.8 Concordia International Corp.
7.6.4.8.1 Company overview
7.6.4.8.2 Regional Sales
7.6.4.8.3 Drug Portfolio
7.6.4.9 Shire Pharmaceuticals Group
7.6.4.9.1 Company overview
7.6.4.9.2 Regional Sales
7.6.4.9.3 Drug Portfolio
7.6.4.10 Vectura Group plc
7.6.4.10.1 Company overview
7.6.4.10.2 Regional Sales
7.6.4.10.3 Drug Portfolio
7.6.5 India
7.6.5.1 Sun Pharmaceutical Industries Ltd
7.6.5.1.1 Company overview
7.6.5.1.2 Regional Sales
7.6.5.1.3 Drug Portfolio
7.6.5.2 Lupin Limited
7.6.5.2.1 Company overview
7.6.5.2.2 Regional Sales
7.6.5.2.3 Drug Portfolio
7.6.5.3 Dr. Reddy’s Laboratories Ltd
7.6.5.3.1 Company overview
7.6.5.3.2 Regional Sales
7.6.5.3.3 Drug Portfolio
7.6.5.4 Cipla Inc.
7.6.5.4.1 Company overview
7.6.5.4.2 Regional Sales
7.6.5.4.3 Drug Portfolio
7.6.5.5 Aurobindo Pharma Limited
7.6.5.5.1 Company overview
7.6.5.5.2 Regional Sales
7.6.5.5.3 Drug Portfolio
7.6.5.6 Zydus Cadila
7.6.5.6.1 Company overview
7.6.5.6.2 Regional Sales
7.6.5.6.3 Drug Portfolio
7.6.5.7 Glenmark Pharmaceuticals Ltd.
7.6.5.7.1 Company overview
7.6.5.7.2 Regional Sales
7.6.5.7.3 Drug Portfolio
7.6.5.8 Torrent Pharmaceuticals Ltd
7.6.5.8.1 Company overview
7.6.5.8.2 Regional Sales
7.6.5.8.3 Drug Portfolio
7.6.5.9 Piramal Enterprises Ltd
7.6.5.9.1 Company overview
7.6.5.9.2 Drug Portfolio
7.6.5.10 Novozymes
7.6.5.10.1 Company overview
7.6.5.10.2 Regional Sales
7.6.6 Spain
7.6.6.1 ESTEVE PHARMA
7.6.6.1.1 Company overview
7.6.6.1.2 Drug Portfolio
7.6.6.2 Curaxys
7.6.6.2.1 Company overview
7.6.6.2.2 Drug Portfolio
7.6.6.3 GRIFOLS INTERNATIONAL, S.A.
7.6.6.3.1 Company overview
7.6.6.3.2 Regional Sales
7.6.6.3.3 Drug Portfolio
7.6.6.4 PharmaMar
7.6.6.4.1 Company overview
7.6.6.4.2 Drug Portfolio
7.6.6.5 SOM Innovation Biotech, S.L.
7.6.6.5.1 Company overview
7.6.6.5.2 Drug Portfolio
7.6.6.6 Ferrer Internacional, S.A.
7.6.6.6.1 Company overview
7.6.6.6.2 Drug Portfolio
7.6.6.7 TEVA PHARMACEUTICAL INDUSTRIES LIMITED
7.6.6.7.1 Company overview
7.6.6.7.2 Regional Sales
7.6.6.7.3 Drug Portfolio
7.6.6.8 A. Menarini Industrie Farmaceutiche Riunite Srl
7.6.6.8.1 Company overview
7.6.6.8.2 Drug Portfolio
7.6.6.9 ADIENNE
7.6.6.9.1 Company overview
7.6.6.9.2 Drug Portfolio
7.6.7 China
7.6.7.1 Shanghai Pharmaceuticals Holding Co., Ltd
7.6.7.1.1 Company overview
7.6.7.1.2 Regional Sales
7.6.7.1.3 Drug Portfolio
7.6.7.2 Weigao group
7.6.7.2.1 Company overview
7.6.7.2.2 Regional Sales
7.6.7.3 CSPC Pharmaceutical Group Limited
7.6.7.3.1 Company overview
7.6.7.3.2 Regional Sales
7.6.7.3.3 Drug Portfolio
7.6.7.4 Furen Pharmaceutical Group Co., Ltd.
7.6.7.4.1 Company overview
7.6.7.4.2 Drug Portfolio
7.6.7.5 China Resources Pharmaceutical Group Limited
7.6.7.5.1 Company overview
7.6.7.5.2 Drug Portfolio
7.6.7.6 Sino Biopharmaceutical Limited
7.6.7.6.1 Company overview
7.6.7.6.2 Drug Portfolio
7.6.7.7 Humanwell Healthcare (Group) Co., Ltd
7.6.7.7.1 Company overview
7.6.7.7.2 Drug Portfolio
7.6.7.8 Sihuan Pharmaceutical Holdings Group Ltd.
7.6.7.8.1 Company overview
7.6.7.8.2 Drug Portfolio
7.6.8 Japan
7.6.8.1 Takeda Pharmaceutical Company Limited
7.6.8.1.1 Company overview
7.6.8.1.2 Regional Sales
7.6.8.1.3 Drug Portfolio
7.6.8.2 Daiichi Sankyo Company, Limited
7.6.8.2.1 Company overview
7.6.8.2.2 Regional Sales
7.6.8.2.3 Drug Portfolio
7.6.8.3 Astellas Pharma Inc.
7.6.8.3.1 Company overview
7.6.8.3.2 Regional Sales
7.6.8.3.3 Drug Portfolio
7.6.8.4 Eisai Co., Ltd.
7.6.8.4.1 Company overview
7.6.8.4.2 Regional Sales
7.6.8.4.3 Drug Portfolio
7.6.8.5 Mitsubishi Tanabe Pharma Corporation
7.6.8.5.1 Company overview
7.6.8.5.2 Drug Portfolio
7.6.8.6 Kyowa Hakko Kirin Co., Ltd
7.6.8.6.1 Company overview
7.6.8.6.2 Regional Sales
7.6.8.6.3 Drug Portfolio
7.6.8.7 Nippon Shinyaku Co Ltd
7.6.8.7.1 Company overview
7.6.8.7.2 Drug Portfolio
7.6.8.8 OtsU.K.a Holdings Co Ltd
7.6.8.8.1 Company overview
7.6.8.8.3 Drug Portfolio
7.6.8.9 Shionogi & Co., Ltd.
7.6.8.9.1 Company overview
7.6.8.9.2 Regional Sales
7.6.8.9.3 Drug Portfolio
7.6.8.10 Dainippon Sumitomo Pharma Co., Ltd.
7.6.8.10.1 Company overview
7.6.8.10.2 Regional Sales
7.6.8.10.3 Drug Portfolio
7.6.9 South Korea
7.6.9.1 YUHAN
7.6.9.1.1 Company overview
7.6.9.1.2 Drug Portfolio
7.6.9.2 Aju Pharm Co. Ltd
7.6.9.2.1 Company overview
7.6.9.2.2 Drug Portfolio
7.6.9.3 Republic of Korea Arlico Pharm. Co., Ltd.
7.6.9.3.1 Company overview
7.6.9.3.2 Drug Portfolio
7.6.9.4 Binex Co., Ltd.
7.6.9.4.1 Company overview
7.6.9.4.2 Drug Portfolio
7.6.9.5 Boryung Pharmaceutical Co., Ltd.
7.6.9.5.1 Company overview
7.6.9.5.2 Drug Portfolio
7.6.9.6 CHO-A PHARM.CO., LTD
7.6.9.6.1 Company overview
7.6.9.6.2 Drug Portfolio
7.6.9.7 CHONG KUN DANG PHARMACEUTICAL CORP
7.6.9.7.1 Company overview
7.6.9.7.2 Drug Portfolio
7.6.9.8 CJ HealthCare Corp.
7.6.9.8.1 Company overview
7.6.9.8.2 Drug Portfolio
7.6.9.9 Hanmi Pharm.Co., Ltd.
7.6.9.9.1 Company overview
7.6.9.9.2 Drug Portfolio
7.6.9.10 Celltrion
7.6.9.10.1 Company overview
7.6.9.10.2 Drug Portfolio
7.6.10 Brazil
7.6.10.1 Aché Laboratórios Farmacêuticos S.A
7.6.10.1.1 Company overview
7.6.10.1.2 Drug Portfolio
7.6.10.2 Hypermarcas
7.6.10.2.1 Company overview
7.6.10.2.2 Drug Portfolio
7.6.10.3 Eurofarma Laboratórios S.A.
7.6.10.3.1 Company overview
7.6.10.3.2 Regional Sales
7.6.10.4 Libbs Farmaceutica Ltd.
7.6.10.4.1 Company overview
7.6.10.4.2 Drug Portfolio
7.6.10.5 União Química
7.6.10.5.1 Company overview
7.6.10.5.2 Drug Portfolio
7.6.10.6 Blanver Farmacêutica
7.6.10.6.1 Company overview
7.6.10.6.2 Drug Portfolio
7.6.10.7 CHIESI Farmaceutici S.p.A.
7.6.10.7.1 Company overview
7.6.10.7.2 Regional Sales
7.6.10.7.3 Drug Portfolio
7.6.10.8 Huvepharma
7.6.10.8.1 Company overview
7.6.10.8.2 Drug Portfolio
Chapter 8 Company Profiles
8.1 Corning Incorporated
8.1.1 Company overview
8.1.2 Financial performance
8.1.3 Product benchmarking
8.1.4 Strategic initiatives
8.2 Nipro Corporation
8.2.1 Company overview
8.2.2 Financial performance
8.2.3 Product benchmarking
8.2.4 Strategic initiatives
8.3 SGD S.A.
8.3.1 Company overview
8.3.2 Financial performance
8.3.3 Product benchmarking
8.3.4 Strategic initiatives
8.4 Stölzle-Oberglas GmbH
8.4.1 Company overview
8.4.2 Financial performance
8.4.3 Product benchmarking
8.5 West Pharmaceutical Services, Inc.
8.5.1 Company overview
8.5.2 Financial performance
8.5.3 Product benchmarking
8.6 Schott AG
8.6.1 Company overview
8.6.2 Financial performance
8.6.3 Product benchmarking
8.6.4 Strategic initiatives
8.7 Gerresheimer AG
8.7.1 Company overview
8.7.2 Financial performance
8.7.3 Product benchmarking
8.7.4 Strategic initiatives
8.8 Bormioli Pharma S.r.l
8.8.1 Company overview
8.8.2 Product benchmarking
8.8.3 Strategic Initiatives
8.9 Shandong Medicinal Glass Co., Ltd.
8.9.1 Company overview
8.9.2 Financial performance
8.9.3 Product benchmarking
8.10 Beatson Clark
8.10.1 Company overview
8.10.2 Financial performance
8.10.3 Product benchmarking
8.10.4 Strategic initiatives
8.11 Ardagh Group S.A.
8.11.1 Company overview
8.11.2 Financial performance
8.11.3 Product benchmarking
8.12 Arab Pharmaceutical Glass Co.
8.12.1 Company overview
8.12.2 Product benchmarking
8.13 Piramal Enterprises Ltd.
8.13.1 Company overview
8.13.2 Financial performance
8.13.3 Product benchmarking
8.14 Şişecam Group
8.14.1 Company overview
8.14.2 Financial performance
8.14.3 Product benchmarking
8.14.4 Strategic initiatives
List of Tables
TABLE 1 Pharmaceutical glass vials market estimates & forecasts, 2014 - 2025 (USD Million)
TABLE 2 Pharmaceutical glass vials market revenue, by product, 2014 - 2025 (USD Million)
TABLE 3 Pharmaceutical glass bottle market estimates & forecasts, 2014 - 2025 (USD Million)
TABLE 4 Pharmaceutical glass bottle market value, by product, 2014 - 2025 (USD Million)
TABLE 5 Pharmaceutical glass cartridges & syringes market estimates & forecasts, 2014 - 2025 (USD Million)
TABLE 6 Pharmaceutical glass ampoules market estimates & forecasts, 2014 - 2025 (USD Million)
TABLE 7 Pharmaceutical glass packaging market estimates & forecasts in generic drugs, 2014 - 2025 (USD Million)
TABLE 8 Pharmaceutical glass packaging market estimates & forecasts in branded drugs, 2014 - 2025 (USD Million)
TABLE 9 Global pharmaceutical glass packaging market estimates & forecasts in biologic drugs, 2014 - 2025 (USD Million)
TABLE 10 North America pharmaceutical glass packaging market revenue, by product, 2014 - 2025 (USD Million)
TABLE 11 North America pharmaceutical glass vials market revenue, by product, 2014 - 2025 (USD Million)
TABLE 12 North America pharmaceutical glass bottles market revenue, by product, 2014 - 2025 (USD Million)
TABLE 13 North America pharmaceutical glass packaging market revenue, by drug type, 2014 - 2025 (USD Million)
TABLE 14 U.S. pharmaceutical glass packaging market revenue, by product, 2014 - 2025 (USD Million)
TABLE 15 U.S. Pharmaceutical glass vials market revenue, by product, 2014 - 2025 (USD Million)
TABLE 16 U.S. Pharmaceutical glass bottles market revenue, by product, 2014 - 2025 (USD Million)
TABLE 17 U.S. pharmaceutical glass packaging market revenue, by drug type, 2014 - 2025 (USD Million)
TABLE 18 Europe pharmaceutical glass packaging market revenue, by product, 2014 - 2025 (USD Million)
TABLE 19 Europe Pharmaceutical glass vials market revenue, by product, 2014 - 2025 (USD Million)
TABLE 20 Europe Pharmaceutical glass bottles market revenue, by product, 2014 - 2025 (USD Million)
TABLE 21 Europe pharmaceutical glass packaging market revenue, by drug type, 2014 - 2025 (USD Million)
TABLE 22 Germany pharmaceutical glass packaging market revenue, by product, 2014 - 2025 (USD Million)
TABLE 23 Germany pharmaceutical glass vials market revenue, by product, 2014 - 2025 (USD Million)
TABLE 24 Germany pharmaceutical glass bottles market revenue, by product, 2014 - 2025 (USD Million)
TABLE 25 Germany pharmaceutical glass packaging market revenue, by drug type, 2014 - 2025 (USD Million)
TABLE 26 U.K. pharmaceutical glass packaging market revenue, by product, 2014 - 2025 (USD Million)
TABLE 27 U.K. Pharmaceutical glass vials market revenue, by product, 2014 - 2025 (USD Million)
TABLE 28 U.K. Pharmaceutical glass bottles market revenue, by product, 2014 - 2025 (USD Million)
TABLE 29 U.K. pharmaceutical glass packaging market revenue, by drug type, 2014 - 2025 (USD Million)
TABLE 30 France pharmaceutical glass packaging market revenue, by product, 2014 - 2025 (USD Million)
TABLE 31 France pharmaceutical glass vials market revenue, by product, 2014 - 2025 (USD Million)
TABLE 32 France pharmaceutical glass bottles market revenue, by product, 2014 - 2025 (USD Million)
TABLE 33 France pharmaceutical glass packaging market revenue, by drug type, 2014 - 2025 (USD Million)
TABLE 34 Spain pharmaceutical glass packaging market revenue, by product, 2014 - 2025 (USD Million)
TABLE 35 Spain pharmaceutical glass vials market revenue, by product, 2014 - 2025 (USD Million)
TABLE 36 Spain pharmaceutical glass bottles market revenue, by product, 2014 - 2025 (USD Million)
TABLE 37 Spain pharmaceutical glass packaging market revenue, by drug type, 2014 - 2025 (USD Million)
TABLE 38 Italy pharmaceutical glass packaging market revenue, by product, 2014 - 2025 (USD Million)
TABLE 39 Italy pharmaceutical glass vials market revenue, by product, 2014 - 2025 (USD
TABLE 40 Italy pharmaceutical glass bottles market revenue, by product, 2014 - 2025 (USD Million)
TABLE 41 Italy pharmaceutical glass packaging market revenue, by drug type, 2014 - 2025 (USD Million)
TABLE 42 Asia Pacific pharmaceutical glass packaging market revenue, by product, 2014 - 2025 (USD Million)
TABLE 43 Asia Pacific Pharmaceutical glass vials market revenue, by product, 2014 - 2025 (USD Million)
TABLE 44 Asia Pacific Pharmaceutical glass bottles market revenue, by product, 2014 - 2025 (USD Million)
TABLE 45 Asia Pacific pharmaceutical glass packaging market revenue, by drug type, 2014 - 2025 (USD Million)
TABLE 46 China pharmaceutical glass packaging market revenue, by product, 2014 - 2025 (USD Million)
TABLE 47 China Pharmaceutical glass vials market revenue, by product, 2014 - 2025 (USD Million)
TABLE 48 China pharmaceutical glass bottles market revenue, by product, 2014 - 2025 (USD Million)
TABLE 49 China pharmaceutical glass packaging market revenue, by drug type, 2014 - 2025 (USD Million)
TABLE 50 Japan pharmaceutical glass packaging market revenue, by product, 2014 - 2025 (USD Million)
TABLE 51 Japan Pharmaceutical glass vials market revenue, by product, 2014 - 2025 (USD Million)
TABLE 52 Japan Pharmaceutical glass bottles market revenue, by product, 2014 - 2025
TABLE 53 Japan pharmaceutical glass packaging market revenue, by drug type, 2014 - 2025 (USD Million)
TABLE 54 India pharmaceutical glass packaging market revenue, by product, 2014 - 2025 (USD Million)
TABLE 55 India pharmaceutical glass vials market revenue, by product, 2014 - 2025 (USD Million)
TABLE 56 India pharmaceutical glass bottles market revenue, by product, 2014 - 2025 (USD Million)
TABLE 57 India pharmaceutical glass packaging market revenue, by drug type, 2014 - 2025 (USD Million)
TABLE 58 South Korea pharmaceutical glass packaging market revenue, by product, 2014 - 2025 (USD Million)
TABLE 59 South Korea pharmaceutical glass vials market revenue, by product, 2014 - 2025 (USD Million)
TABLE 60 South Korea pharmaceutical glass bottles market revenue, by product, 2014 - 2025 (USD Million)
TABLE 61 South Korea pharmaceutical glass packaging market revenue, by drug type, 2014 - 2025 (USD Million)
TABLE 62 CSA pharmaceutical glass packaging market revenue, by product, 2014 - 2025 (USD Million)
TABLE 63 CSA pharmaceutical glass vials market revenue, by product, 2014 - 2025 (USD Million)
TABLE 64 CSA pharmaceutical glass bottles market revenue, by product, 2014 - 2025 (USD Million)
TABLE 65 CSA pharmaceutical glass packaging market revenue, by drug type, 2014 - 2025 (USD Million)
TABLE 66 Brazil pharmaceutical glass packaging market revenue, by product, 2014 - 2025 (USD Million)
TABLE 67 Brazil pharmaceutical glass vials market revenue, by product, 2014 - 2025 (USD Million)
TABLE 68 Brazil pharmaceutical glass bottles market revenue, by product, 2014 - 2025 (USD Million)
TABLE 69 Brazil pharmaceutical glass packaging market revenue, by drug type, 2014 - 2025 (USD Million)
TABLE 70 MEA pharmaceutical glass packaging market revenue, by product, 2014 - 2025 (USD Million)
TABLE 71 MEA pharmaceutical glass vials market revenue, by product, 2014 - 2025 (USD Million)
TABLE 72 MEA pharmaceutical glass bottles market revenue, by product, 2014 - 2025 (USD Million)
TABLE 73 MEA pharmaceutical glass packaging market revenue, by drug type, 2014 - 2025 (USD Million)
List of Figures
FIG. 1 Market summary
FIG. 2 Market segmentation & scope
FIG. 3 Penetration & growth prospect mapping
FIG. 4 Pharmaceutical glass packaging market - Value chain analysis
FIG. 5 World boron reserves, 2016 (%)
FIG. 6 Boron demand, by application, 2016 (%)
FIG. 7 Market dynamics
FIG. 8 Market driver relevance analysis (Current & future impact)
FIG. 9 Pharma market development, 2006 - 2016 (USD Billion)
FIG. 10 Market restraint relevance analysis (Current & future impact)
FIG. 11 Global plastic & polymer pharmaceutical packaging industry, 2014 - 2025 (USD Billion)
FIG. 12 Pharmaceutical glass packaging market - PESTEL analysis
FIG. 13 Pharmaceutical glass packaging market - Porter’s analysis
FIG. 14 Pharmaceutical glass packgaing market outlook: Key takeaways
FIG. 15 Pharmaceutical glass packaging market: Product movement analysis, 2016 & 2025
FIG. 16 Pharmaceutical glass packaging drug type outlook: Key takeaways
FIG. 17 Pharmaceutical glass packaging market: Drug type movement analysis, 2016 & 2025
FIG. 18 Regional market place: Key takeaways
FIG. 19 Pharmaceutical glass packaging market: Regional movement analysis, 2016 & 2025
FIG. 20 North America market revenue estimates (2014 - 2025) (USD Million)
FIG. 21 U.S. country outlook, 2014 to 2025 (USD Million)
FIG. 22 Europe market revenue estimates (2014 - 2025) (USD Million)
FIG. 23 Germany country outlook, 2014 to 2025 (USD Million)
FIG. 24 U.K. country outlook, 2014 to 2025 (USD Million)
FIG. 25 France country outlook, 2014 to 2025 (USD Million)
FIG. 26 Spain country outlook, 2014 to 2025 (USD Million)
FIG. 27 Italy country outlook, 2014 to 2025 (USD Million)
FIG. 28 Asia Pacific market revenue estimates (2014 - 2025) (USD Million)
FIG. 29 China country outlook, 2014 to 2025 (USD Million)
FIG. 30 Japan country outlook, 2014 to 2025 (USD Million)
FIG. 31 India country outlook, 2014 to 2025 (USD Million)
FIG. 32 South Korea country outlook, 2014 to 2025 (USD Million)
FIG. 33 CSA market revenue estimates (2014 - 2025) (USD Million)
FIG. 34 Brazil country outlook, 2014 to 2025 (USD Million)
FIG. 35 MEA market revenue estimates (2014 - 2025) (USD Million)
FIG. 36 Average selling price of pharmaceutical glass packaging products, 2016 (USD/unit)
FIG. 37 Strategy framework

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report